203 related articles for article (PubMed ID: 31409639)
1. LOXL2 Upregulates Phosphorylation of Ezrin to Promote Cytoskeletal Reorganization and Tumor Cell Invasion.
Zhan XH; Jiao JW; Zhang HF; Xu XE; He JZ; Li RL; Zou HY; Wu ZY; Wang SH; Wu JY; Liao LD; Wang JJ; Cheng YW; Zhang K; Neufeld G; Xu LY; Li EM
Cancer Res; 2019 Oct; 79(19):4951-4964. PubMed ID: 31409639
[TBL] [Abstract][Full Text] [Related]
2. Heat shock protein family B member 1 facilitates ezrin activation to control cell migration in esophageal squamous cell carcinoma.
Xie YH; Li LY; He JZ; Xu XE; Liao LD; Zhang Q; Xie JJ; Xu LY; Li EM
Int J Biochem Cell Biol; 2019 Jul; 112():79-87. PubMed ID: 31082616
[TBL] [Abstract][Full Text] [Related]
3. SMYD3 stimulates EZR and LOXL2 transcription to enhance proliferation, migration, and invasion in esophageal squamous cell carcinoma.
Zhu Y; Zhu MX; Zhang XD; Xu XE; Wu ZY; Liao LD; Li LY; Xie YM; Wu JY; Zou HY; Xie JJ; Li EM; Xu LY
Hum Pathol; 2016 Jun; 52():153-63. PubMed ID: 26980013
[TBL] [Abstract][Full Text] [Related]
4. Ezrin Ser66 phosphorylation regulates invasion and metastasis of esophageal squamous cell carcinoma cells by mediating filopodia formation.
Li LY; Xie YH; Xie YM; Liao LD; Xu XE; Zhang Q; Zeng FM; Tao LH; Xie WM; Xie JJ; Xu LY; Li EM
Int J Biochem Cell Biol; 2017 Jul; 88():162-171. PubMed ID: 28504189
[TBL] [Abstract][Full Text] [Related]
5. LOXL2-dependent deacetylation of aldolase A induces metabolic reprogramming and tumor progression.
Jiao JW; Zhan XH; Wang JJ; He LX; Guo ZC; Xu XE; Liao LD; Huang X; Wen B; Xu YW; Hu H; Neufeld G; Chang ZJ; Zhang K; Xu LY; Li EM
Redox Biol; 2022 Nov; 57():102496. PubMed ID: 36209516
[TBL] [Abstract][Full Text] [Related]
6. A three-gene signature from protein-protein interaction network of LOXL2- and actin-related proteins for esophageal squamous cell carcinoma prognosis.
Zhan XH; Jiao JW; Zhang HF; Li CQ; Zhao JM; Liao LD; Wu JY; Wu BL; Wu ZY; Wang SH; Du ZP; Shen JH; Zou HY; Neufeld G; Xu LY; Li EM
Cancer Med; 2017 Jul; 6(7):1707-1719. PubMed ID: 28556501
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel lysyl oxidase-like 2 alternative splicing isoform, LOXL2 Δe13, in esophageal squamous cell carcinoma.
Lv GQ; Zou HY; Liao LD; Cao HH; Zeng FM; Wu BL; Xie JJ; Fang WK; Xu LY; Li EM
Biochem Cell Biol; 2014 Oct; 92(5):379-89. PubMed ID: 25275797
[TBL] [Abstract][Full Text] [Related]
8. L1CAM drives oncogenicity in esophageal squamous cell carcinoma by stimulation of ezrin transcription.
Guo JC; Xie YM; Ran LQ; Cao HH; Sun C; Wu JY; Wu ZY; Liao LD; Zhao WJ; Fang WK; Li EM; Xu LY; Schachner M; Xie JJ
J Mol Med (Berl); 2017 Dec; 95(12):1355-1368. PubMed ID: 28939985
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of AKT by lysyl oxidase-like 2 activates the PI3K/AKT signaling pathway to promote proliferation, invasion and metastasis in esophageal squamous carcinoma.
Fan Z; Liu Y; Liu X; Nian W; Huang X; Yang Q; Hou S; Chen F
Clin Transl Oncol; 2023 Aug; 25(8):2487-2498. PubMed ID: 36995521
[TBL] [Abstract][Full Text] [Related]
10. A truncated splice variant of human lysyl oxidase-like 2 promotes migration and invasion in esophageal squamous cell carcinoma.
Zou HY; Lv GQ; Dai LH; Zhan XH; Jiao JW; Liao LD; Zhou TM; Li CQ; Wu BL; Xu LY; Li EM
Int J Biochem Cell Biol; 2016 Jun; 75():85-98. PubMed ID: 27063404
[TBL] [Abstract][Full Text] [Related]
11. Lysyl oxidase-like 2 promotes esophageal squamous cell carcinoma cell migration independent of catalytic activity.
Zou H; Wen B; Li RL; Zhan XH; Jiao JW; Liao LD; Wu BL; Xie WM; Xu LY; Li EM
Int J Biochem Cell Biol; 2020 Aug; 125():105795. PubMed ID: 32580015
[TBL] [Abstract][Full Text] [Related]
12. A decision tree-based combination of ezrin-interacting proteins to estimate the prognostic risk of patients with esophageal squamous cell carcinoma.
He JZ; Wu ZY; Wang SH; Ji X; Yang CX; Xu XE; Liao LD; Wu JY; Li EM; Zhang K; Xu LY
Hum Pathol; 2017 Aug; 66():115-125. PubMed ID: 28603065
[TBL] [Abstract][Full Text] [Related]
13. Ezrin T567 phosphorylation regulates migration and invasion of ectopic endometrial stromal cells by changing actin cytoskeleton.
Chen C; Ye C; Xia J; Zhou Y; Wu R
Life Sci; 2020 Aug; 254():117681. PubMed ID: 32380081
[TBL] [Abstract][Full Text] [Related]
14. The interaction of lncRNA EZR-AS1 with SMYD3 maintains overexpression of EZR in ESCC cells.
Zhang XD; Huang GW; Xie YH; He JZ; Guo JC; Xu XE; Liao LD; Xie YM; Song YM; Li EM; Xu LY
Nucleic Acids Res; 2018 Feb; 46(4):1793-1809. PubMed ID: 29253179
[TBL] [Abstract][Full Text] [Related]
15. A protein complex of LCN2, LOXL2 and MMP9 facilitates tumour metastasis in oesophageal cancer.
Xia Q; Du Z; Chen M; Zhou X; Bai W; Zheng X; Lin L; Zhao Y; Ding J; Wu Z; Zou H; Wang S; Xu L; Li E; Wu B
Mol Oncol; 2023 Nov; 17(11):2451-2471. PubMed ID: 37753805
[TBL] [Abstract][Full Text] [Related]
16. LOXL2 in cancer: regulation, downstream effectors and novel roles.
Wen B; Xu LY; Li EM
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188435. PubMed ID: 32976981
[TBL] [Abstract][Full Text] [Related]
17. LncRNA CASC9 promotes esophageal squamous cell carcinoma metastasis through upregulating LAMC2 expression by interacting with the CREB-binding protein.
Liang Y; Chen X; Wu Y; Li J; Zhang S; Wang K; Guan X; Yang K; Bai Y
Cell Death Differ; 2018 Nov; 25(11):1980-1995. PubMed ID: 29511340
[TBL] [Abstract][Full Text] [Related]
18. PPI network analysis of mRNA expression profile of ezrin knockdown in esophageal squamous cell carcinoma.
Wu B; Xie J; Du Z; Wu J; Zhang P; Xu L; Li E
Biomed Res Int; 2014; 2014():651954. PubMed ID: 25126570
[TBL] [Abstract][Full Text] [Related]
19. Receptor activity modifying protein-3 mediates the protumorigenic activity of lysyl oxidase-like protein-2.
Brekhman V; Lugassie J; Zaffryar-Eilot S; Sabo E; Kessler O; Smith V; Golding H; Neufeld G
FASEB J; 2011 Jan; 25(1):55-65. PubMed ID: 20802105
[TBL] [Abstract][Full Text] [Related]
20. F806 Suppresses the Invasion and Metastasis of Esophageal Squamous Cell Carcinoma via Downregulating F-Actin Assembly-Related Rho Family Proteins.
Xie L; Li LY; Zheng D; Xie YM; Xu XE; Tao LH; Liao LD; Xie YH; Cheng YW; Xu LY; Li EM
Biomed Res Int; 2018; 2018():2049313. PubMed ID: 30327774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
